Jacques Rachelle Suzanne
SEC CIK 1772610 · EDGAR
BoughtSold
Most active insiders at QURE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kapusta Matthew C | CEO, Managing Dir, Dir | — | $12.86M |
| 2 | Kaye Jack | Dir | — | $2.69M |
| 3 | Abi-Saab Walid | Chief Medical Off | — | $2.61M |
| 4 | Gut Robert | Dir | — | $1.76M |
| 5 | Balachandran Madhavan | Dir | — | $858.9K |
| 6 | O'Keefe Kylie | Chief Customer, Strat Off | — | $431.2K |
| 7 | KLEMT CHRISTIAN | CFO | — | $381.8K |
| 8 | Potts Jeannette | CLO | — | $261.2K |
| 9 | Jacques Rachelle Suzanne | Dir | — | $53.9K |
| 10 | Springhorn Jeremy P. | Dir | — | $53.9K |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 17:15 | 2026-06-10 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Dir | A - Grant | $0.00 | +7,550 | 35.9K | +27% | $0 |
| D | 2026-06-12 17:15 | 2026-06-11 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Dir | S - Sale | $27.06 | -1,993 | 33.9K | -6% | -$53.9K |
| D | 2026-05-21 17:06 | 2026-05-19 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Jacques Rachelle Suzanne | Dir | A - Grant | $0.00 | +3,800 | 11.4K | +50% | $0 |
| 2025-06-24 | 2025-06-20 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Dir | S - Sale | $14.45 | -2,112 | 28.3K | -7% | -$30.5K | |
| D | 2025-06-13 | 2025-06-11 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Dir | A - Grant | $0.00 | +7,970 | 30.5K | +35% | $0 |
| D | 2025-06-02 | 2025-05-30 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Jacques Rachelle Suzanne | Dir | A - Grant | $0.00 | +4,800 | 7,583 | +172% | $0 |
| D | 2024-06-21 | 2024-06-19 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Dir | A - Grant | $0.00 | +8,080 | 22.5K | +56% | $0 |
| 2024-06-17 | 2024-06-13 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Dir | S - Sale | $5.14 | -2,221 | 14.4K | -13% | -$11.4K | |
| 2024-06-03 | 2024-05-30 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Jacques Rachelle Suzanne | Dir | A - Grant | $0.00 | +2,783 | 2,783 | New | $0 | |
| 2024-04-30 | 2024-04-26 | AKTX | Akari Therapeutics Plc | Jacques Rachelle Suzanne | CEO, Dir | A - Grant | $0.00 | +479.57M | 1.02B | +89% | $0 | |
| D | 2023-06-20 | 2023-06-13 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Dir | A - Grant | $0.00 | +8,700 | 18.9K | +85% | $0 |
| D | 2023-06-20 | 2023-06-16 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Dir | S - Sale | $18.76 | -2,301 | 16.6K | -12% | -$43.2K |
| 2023-03-01 | 2023-02-27 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Dir | S - Sale | $20.02 | -384 | 10.2K | -4% | -$7,688 | |
| D | 2022-06-17 | 2022-06-15 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Dir | A - Grant | $0.00 | +9,080 | 10.6K | +592% | $0 |
| D | 2022-02-28 | 2022-02-24 | QURE | uniQure N.V. | Jacques Rachelle Suzanne | Dir | A - Grant | $0.00 | +1,534 | 1,534 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations